Bioinformatics is the utilization of computer sciences in the fields of genomics, molecular sciences, or in other words, computational knowledge for the analysis of vast molecular information.The expansion of genomic and protein databases and the need for data analysis led to the emergence of bioinformatics.The role of bioinformatics in the pharmaceutical industry is undeniable.The deployment of drug design software and bioinformatics analysis not only accelerates the identification of drug targets but also facilitates the identification of drug side effects and drug resistance.Nowadays, bioinformatics is used to examine drug effects, produce drugs with the maximum impact, and reduce drug production costs.In general, this review aims to investigate the role of bioinformatics in the drug design process and provides explanations on bioinformatics and drug discovery, validation of drug targets, cost reduction, encouragement of new drug development, breakthroughs in bioinformatics in the drug design process, and pharmacogenomics in drug discovery and development using various articles.In conclusion, drug design is a complex process that bioinformatics can facilitate by producing highly effective drugs, identifying targets, reducing resistance, and drug costs .
No takes yet. Share an insight, caveat, or question.
Bahrami et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: